دولوتيجرافير صوديوم
| Kind | API |
|---|---|
| Class | Antiviral — integrase strand-transfer inhibitor (INSTI) |
| Synonyms | DTG, Dolutegravir Na, Tivicay |
| Common uses / forms | Oral tablets for HIV-1; WHO-preferred first-line as TLD (tenofovir/lamivudine/dolutegravir) |
| Properties | BCS Class II (low, pH-dependent solubility, high permeability); sodium salt; chelates polyvalent metal cations (Mg/Ca/Fe/Al) |
| Compendia | USP, IP |
| Sourcing origins | India, China |
| Dominant inbound route | Hormuz |
| Indicative price band | $$$ ($100–1000 / kg) |
| Indicative lead time | medium (50–80 days) |
| Notes | WHO first-line; MPP/voluntary-licence generic supply (multiple Indian makers, so not single-source); cation chelation drives dosing-spacing and formulation care; patent status varies by market. Kept USP+IP only (EP/BP not claimed — recent molecule) |
Open the interactive Data Bank (363 substances) · the full table · Supply Resilience Studio
Share: LinkedIn · X · WhatsApp · Telegram · Email
Cite as: AUPAM Experts' Office, Dolutegravir sodium — sourcing profile (API) — AUPAM Data Bank, retrieved 2026-08-31, https://aupameo.org/datasets/databank/a-dolutegravir-sodium.html